Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
Pneumococcal disease
Type of publications
NITAG documentation (88)
Reports (1)
SAGE documentation (12)
Scientific publications (1)
Systematic reviews (SYSVAC) (168)
Regions
Africa (11)
Americas (52)
Eastern Mediterranean (1)
Europe (39)
South-East Asia (4)
Western Pacific (15)
Diseases
Pneumococcal disease (270)
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (9)
Moderate (2)
Low (13)
Critically low (80)
Not applicable (64)
270 results found
2025
∙
SAGE
SAGE Evidence to Recommendation Framework: Reduced-dose (1p+1) schedules
2025
∙
WHO
WHO position paper on Pneumococcal conjugate vaccines in infants and children aged <5 years – September 2025
2025
∙
SAGE
SAGE Evidence to Recommendation Framework: Multi-age cohort PCV campaigns
2025
∙
SAGE
SAGE Evidence to Recommendation Framework: Extended-valency PCVs
2025
∙
Ngamprasertchai, T. Ruenroengbun, N. Kajeekul, R.
Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials
2025
∙
Cho, J. Y. Lee, H. Wannaadisai, W. Vietri, J. Chaiyakunapruk, N.
Systematic literature review of cost-effectiveness analyses of adult 15- and 20-valent pneumococcal vaccines
2025
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, March 2025: Conclusions and recommendations
2024
∙
Silverii, G. A. Gabutti, G. Tafuri, S. Sarti, F. Pratesi, A. Clerico, A. Fornengo, R. Greco, C. Irace, C. Sordi, V. Sorice, G. P. Cavallo, M. Ponziani, M. C. Mannucci, E. Dicembrini, I.
Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies
2024
∙
Gebreyesus, A. Tesfay, K.
Effect of maternal education on completing childhood vaccination in Ethiopia: systematic review and meta-analysis
2024
∙
Sepúlveda-Pachón, I. T. Dunne, E. M. Hanquet, G. Baay, M. Menon, S. Jodar, L. Gessner, B. D. Theilacker, C.
Effect of pneumococcal conjugate vaccines on viral respiratory infections: a systematic literature review
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register